
### [NCIT:C4124](http://purl.obolibrary.org/obo/NCIT_C4124)
**Label:** Metastatic Adenocarcinoma

**Subclasses:** [NCIT:C3345](http://purl.obolibrary.org/obo/NCIT_C3345) (Pseudomyxoma Peritonei), [NCIT:C8933](http://purl.obolibrary.org/obo/NCIT_C8933) (Metastatic Pancreatic Adenocarcinoma), [NCIT:C76326](http://purl.obolibrary.org/obo/NCIT_C76326) (Metastatic Ductal Breast Carcinoma), [NCIT:C8944](http://purl.obolibrary.org/obo/NCIT_C8944) (Vaginal Metastatic Adenocarcinoma), [NCIT:C8934](http://purl.obolibrary.org/obo/NCIT_C8934) (Metastatic Small Intestinal Adenocarcinoma), [NCIT:C27185](http://purl.obolibrary.org/obo/NCIT_C27185) (Disseminated Adenocarcinoma), [NCIT:C8945](http://purl.obolibrary.org/obo/NCIT_C8945) (Metastatic Prostatic Adenocarcinoma), [NCIT:C8942](http://purl.obolibrary.org/obo/NCIT_C8942) (Metastatic Endometrial Adenocarcinoma), [NCIT:C8943](http://purl.obolibrary.org/obo/NCIT_C8943) (Metastatic Endometrioid Adenocarcinoma), [NCIT:C5176](http://purl.obolibrary.org/obo/NCIT_C5176) (Metastatic Signet Ring Cell Breast Carcinoma), [NCIT:C66717](http://purl.obolibrary.org/obo/NCIT_C66717) (Metastatic Signet Ring Cell Carcinoma), [NCIT:C3153](http://purl.obolibrary.org/obo/NCIT_C3153) (Krukenberg Tumor), [NCIT:C76328](http://purl.obolibrary.org/obo/NCIT_C76328) (Metastatic Lobular Breast Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.10%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40191](http://purl.obolibrary.org/obo/NCIT_C40191) (Cervical Warty Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 38.69%


